Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty.
All companies · Product and company coverage
In 2025, Atlas Spine reported engagement with 1 surgeons and other clinicians in the states MedaRep covers, worth $500 in consulting, speaking, meals and travel for its device products, the most in New York ($500 to 1). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: New York ($500, 1 engaged).
In the last ten years FDA made 10 decisions for Atlas Spine (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2025 (2). The latest was on 2026-07-15.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 13 |
| Cervical fusion & disc arthroplasty | 7 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-07-15 | 510(k) | K252822 | Atlas Spine HiRISE Expandable Cervical-p Corpectomy Implant |
| 2025-11-10 | 510(k) | K252560 | Atlas Spine HiRISE Expandable Cervical Corpectomy System |
| 2025-08-15 | 510(k) | K251969 | Atlas Spine Project X Expandable Posterior Lumbar Interbody System |
| 2024-11-26 | 510(k) | K243191 | Atlas Spine Lateral Expandable Interbody System |
| 2020-10-30 | 510(k) |
| K202302 |
| Atlas Spine Rebar (Ti) Spacer System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Atlas Spine.